scispace - formally typeset
P

Peter G. Gibson

Researcher at University of Newcastle

Publications -  774
Citations -  53254

Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.

Papers
More filters
Journal ArticleDOI

Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.

TL;DR: Levels in severe asthma and bronchiectasis compared to moderate–severe COPD and to controls are described and the cross‐sectional associations of PA (steps/day) with shared disease characteristics in the OAD group are tested.
Journal ArticleDOI

Induced sputum eosinophils in the assessment of asthma and chronic cough.

TL;DR: To evaluate induced sputum eosinophils in asthma and chronic cough, a large number of patients with chronic cough and a history of asthma are recruited to take part in a sham vaccination trial.
Journal ArticleDOI

Pneumococcal Components Induce Regulatory T Cells That Attenuate the Development of Allergic Airways Disease by Deviating and Suppressing the Immune Response to Allergen

TL;DR: Bacterial components (T+P) drive the differentiation of highly suppressive Tregs, which suppress the Th2 response, prevent the Th17 response and disable the DC response resulting in the effective suppression of AAD.
Journal ArticleDOI

Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease

TL;DR: The upregulation of IL-1 pathway mediators is associated with frequent exacerbations of obstructive airway disease and correlated with the number and severity of exacerbations.
Journal ArticleDOI

Asthma remission: what is it and how can it be achieved?

TL;DR: There is some evidence to show that the current long-term add on therapies such as biologics and azithromycin can achieve some criteria for asthma remission on treatment, at least in a subgroup of patients, however, more research is required.